Literature DB >> 29776605

G Protein-Coupled Receptor Resensitization Paradigms.

Manveen K Gupta1, Maradumane L Mohan1, Sathyamangla V Naga Prasad2.   

Abstract

Cellular responses to extracellular milieu/environment are driven by cell surface receptors that transmit the signal into the cells resulting in a synchronized and measured response. The ability to provide such exquisite responses to changes in external environment is mediated by the tight and yet, deliberate regulation of cell surface receptor function. In this regard, the seven transmembrane G protein-coupled receptors (GPCRs) are the largest family of cell surface receptors that regulate responses like cardiac contractility, vision, and olfaction including platelet activation. GPCRs regulate these plethora of events through GPCR-activation, -desensitization, and -resensitization. External stimuli (ligands or agonists) activate GPCR initiating downstream signals. The activated GPCR undergoes inactivation or desensitization by phosphorylation and binding of β-arrestin resulting in diminution of downstream signals. The desensitized GPCRs are internalized into endosomes, wherein they undergo dephosphorylation or resensitization by protein phosphatase to be recycled back to the cell membrane as naïve GPCR ready for the next wave of stimuli. Despite the knowledge that activation, desensitization, and resensitization shoulder an equal role in maintaining GPCR function, major advances have been made in understanding activation and desensitization compared to resensitization. However, increasing evidence shows that resensitization is exquisitely regulated process, thereby contributing to the dynamic regulation of GPCR function. In recognition of these observations, in this chapter we discuss the key advances on the mechanistic underpinning that drive and regulate GPCR function with a focus on resensitization.
© 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  A-kinase anchoring protein; Desensitization; G protein-coupled receptor kinases; G protein-coupled receptors; Inhibitor of protein phosphatase 2A; PDZ-binding proteins; Phosphoinositide 3-kinase γ; Protein phosphatase 1; Protein phosphatase 2A; Resensitization; β-Arrestin

Mesh:

Substances:

Year:  2018        PMID: 29776605     DOI: 10.1016/bs.ircmb.2018.03.002

Source DB:  PubMed          Journal:  Int Rev Cell Mol Biol        ISSN: 1937-6448            Impact factor:   6.813


  6 in total

1.  Phosphodiesterase 4 mediates interleukin-8-induced heterologous desensitization of the β2 -adrenergic receptor.

Authors:  Thomas C Rich; Silas J Leavesley; Angela P Brandon; Cilina A Evans; S Vamsee Raju; Brant M Wagener
Journal:  FASEB J       Date:  2021-10       Impact factor: 5.834

2.  RTK signaling requires C3ar1/C5ar1 and IL-6R joint signaling to repress dominant PTEN, SOCS1/3 and PHLPP restraint.

Authors:  Michael G Strainic; Elliot Pohlmann; Christopher C Valley; Ajay Sammeta; Wasim Hussain; Diane S Lidke; M Edward Medof
Journal:  FASEB J       Date:  2019-12-13       Impact factor: 5.191

3.  Allyl Isothiocyanate (AITC) Triggered Toxicity and FsYvc1 (a STRPC Family Member) Responded Sense in Fusarium solani.

Authors:  Yingbin Li; Yixiang Liu; Zhiping Zhang; Yongsong Cao; Jianqiang Li; Laixin Luo
Journal:  Front Microbiol       Date:  2020-05-12       Impact factor: 5.640

4.  Neuroendocrine Assessment of Dopaminergic Function during Antidepressant Treatment in Major Depressed Patients.

Authors:  Fabrice Duval; Marie-Claude Mokrani; Alexis Erb; Felix Gonzalez Lopera; Vlad Danila; Mihaela Tomsa
Journal:  Brain Sci       Date:  2021-03-26

5.  CCR6 activation links innate immune responses to mucosa-associated lymphoid tissue lymphoma development.

Authors:  Boguslawa Korona; Dagmara Korona; Wanfeng Zhao; Andrew C Wotherspoon; Ming-Qing Du
Journal:  Haematologica       Date:  2022-06-01       Impact factor: 11.047

6.  Sorting Nexin 27 as a potential target in G protein‑coupled receptor recycling for cancer therapy (Review).

Authors:  Zixu Bao; Shijun Zhou; Haisheng Zhou
Journal:  Oncol Rep       Date:  2020-09-14       Impact factor: 3.906

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.